PER 34.1% 8.9¢ percheron therapeutics limited

Ann: Antisense Therapeutics Corporate Presentation, page-48

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 153 Posts.
    lightbulb Created with Sketch. 129
    Haha, i'm glad that you said that for our benefit. AF also deserves some of his flowers after getting so much flak from us.

    @BoomCrashOffera I believe slide 9 has all the possibilities outlined. #4 has the Phase IIB + the Confirmatory Trial option prior to Full FDA Approval. All the options and its variants are laid out.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.